Neurogene (NGNE) Net Income (2013 - 2026)
Neurogene's Net Income was -$34.62 million in Q2 2026, compared with -$23.15 million a year earlier.
Analysis
Neurogene (NGNE) Net Income (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurogene's Net Income was -$111.63 million through Jun 30, 2026; for FY2025, it was -$91.79 million.
- In earlier years, Net Income was -$74.15 million in FY2024, -$52.64 million in FY2023, -$55.18 million in FY2022 and -$60.7 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Net Income since Q3 2019.
- Per Business Quant data, NGNE's Net Income in the three quarters before Q2 2026 was -$31.09 million (Q1 2026), -$24.86 million (Q4 2025) and -$21.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Neurogene | 627.40 Mn | 627.40 Mn | - | -34.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.62 Mn |
| Mar 31, 2026 | -31.09 Mn |
| Dec 31, 2025 | -24.86 Mn |
| Sep 30, 2025 | -21.06 Mn |
| Jun 30, 2025 | -23.15 Mn |
| Mar 31, 2025 | -22.72 Mn |
| Dec 31, 2024 | -19.24 Mn |
| Sep 30, 2024 | -20.34 Mn |
| Jun 30, 2024 | -18.10 Mn |
| Mar 31, 2024 | -16.46 Mn |
| Dec 31, 2023 | -13.96 Mn |
| Sep 30, 2023 | -14.57 Mn |
| Jun 30, 2023 | -11.86 Mn |
| Mar 31, 2023 | -12.26 Mn |
| Dec 31, 2022 | -11.67 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -15.87 Mn |
| Mar 31, 2022 | -15.37 Mn |
| Dec 31, 2021 | -15.17 Mn |
| Sep 30, 2021 | -15.45 Mn |
API Access
Neurogene Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=NGNE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();